Giant Cell Arteritis - FOI Response Register

1. Does your trust or health board treat giant cell arteritis (GCA)?  If not, please provide the name of the hospital or trust that you refer GCA patients to.

Yes

2. In the past 3 months, how many patients with a primary diagnosis of GCA (ICD10 codes M31.5 or M31.6) were:

•     Admitted as an inpatient

Nil

•     Treated in A&E

NHS Shetland does not use the ICD 10 coding system for A&E attendances therefore with regards to this in accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested.

3. How many patients were treated by the rheumatology department in the past 3 months with the following:

•     Tocilizumab – for any disease

<5

•     Tocilizumab for rheumatoid arthritis (RA) only

<5

•     Tocilizumab for giant cell arteritis (GCA) only

 Nil

4. How many patients were treated by the ophthalmology department (for any disease) in the past 3 months with Tocilizumab?

Nil

5. How many patients were treated in A&E in the past 3 months for giant cell arteritis (GCA) with Tocilizumab?

Nil

Where we have given <5 answers, this is because NHS Shetland considers that providing more specific information carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects